Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2026-02-25 @ 8:51 PM
Study NCT ID:
NCT06060405
Status:
RECRUITING
Last Update Posted:
2024-01-08
First Post:
2023-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Oleclumab in Resectable PDAC
Sponsor:
University Health Network, Toronto
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Ductal Adenocarcinoma | View |
Keywords: